Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: The potential role of purging with CD34 positive selection

Journal of Clinical Pathology - Clinical Molecular Pathology

Volumn 49, Issue 2, 1996, Pages

  Owen, R G ^a   Haynes, A P ^b   Evans, P A ^c   Johnson, R J ^d   Rawstron, A G ^a   McQuaker, G ^b   Smith, G M ^c   Galvin, M C ^d   Barnard, D L ^a   Russell, N H ^a   Child, J A ^b   Morgan, G J ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

CD34; Myeloma; PCR; Peripheral blood progenitor cells; Purging

Indexed keywords

CD34 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; BLOOD CELL; CELL CLONE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL;

EID: 0029961806     PISSN: 13552910     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.49.2.m112     Document Type: Article

References (23)

1. Gore ME, Selby PJ, Viner C, Clark PI, Meldrum M, Millar B, et al. Intensive treatment of multiple myeloma and criteria for complete remission. Lancet 1989;ii:879-82.
2. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet G, Rossi JF, et al. High dose therapy in multiple myeloma: a prospective randomised study of the "Intergroupe Français du myelome" (abstract). Blood 1994;84(Suppl l):386a.
3. Bird JM, Bloxham D, Samson D, Marcus RE, Russell NH, Kelsey SM, et al. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br J Haematol 1994;88: 110-16.
4. Hardingham JE, Kotasek D, Sage RE, Dubrovic A, Gooley T, Dale BM. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 1993; 11:15-20.
5. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsman R, Kanz L. Mobilisation of tumour cells and haematopoietic progenitor cells in peripheral blood of patients with solid tumours. Blood 199483:636-40.
6. Evans PAS, Shiach CR, Short MA, Morgan GJ, Kinsey SE, Lewis IJ, et al. Use of an automated genescanner to evaluate immunoglobulin gene rearrangements in serial samples from children with ALL. Br J Haematol 1994;86: (Suppl 1):19.
7. Berenson J, Wong R, Kim K, Brown N, Lichtenstein A. Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 1987; 70:1550-3.
8. Chiu EKW, Ganeshaguru K, Hoffbrand AV, Mehta AD. Circulating monoclonal B lymphocytes in multiple myeloma. Br J Haematol 1989;72:28-31.
9. Van Riet I, Heirman C, Lacor P, DeWaele M, Thielemans K, Van Camp B. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. BrJ Haematol 1989;73:289-95.
10. Jensen GS, Mant MJ, Belch AJ, Berenson JR, Reuther BA, Pilarski LM. Selective expression of CD45 isoforms defines CALLA + monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991;78:711-19.
11. Witzig TE, Kyle RA, Greipp PR. Circulating peripheral blood plasma cells in multiple myeloma. Curr Top Microbiol Immunol 1992;182:195-9.
12. Billadeau D, Quam L, Thomas W, Kay N, Griepp P, Kyle R, et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992;80:1818-24.
13. Corradini P, Voena C, Omede P, Astolfi M, Boccadoro M, Dalla Pavera R, et al. Detection of circulating tumour cells in multiple myeloma by a PCR based method. Leukemia 1993;7:1879-82.
14. Johnson RJ, Owen RG, Smith GM, Child JA, Galvin M, Newton LJ, et al. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells. Bone Marrow Transplant 1996 (in press).
15. Ralph QM, Brisco MJ, Joshua DE, Brown RD, Gibson J, Morley AA. Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B cell clone: evidence from the Ig heavy chain gene. Blood 1993;82:202-8.
16. Owen RG, Johnson RJ, Evans PA, Smith GM, Child JA, Morgan GJ. Detection of clonal immunoglobulin gene rearrangements in the PBPC harvests of patients with acute lymphoblastic leukaemia. Bone Marrow Transplant 1995;16:831-4.
17. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro JJ, Anderson WF, et al. Gene marking to trace the origin of relapse after autologous bone marrow transplantation. Lancet 1993;341:85-6.
18. Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994;84: 380-3.
19. Gribben JG, Freedman AS, Neuberg D, Roy D, Blake K, Woo S, et al. Immunologie purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991;325:1525-33.
20. Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, et al. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995;86:390-7.
21. Gazitt Y, Reading CC, Huffman R, Wickrema A, Vesole DH, Jaganath S, et al. Purified CD34 + Lin- Thy + stem cells do not contain clonal myeloma cells. Blood 1995;86: 381-9.
22. Vescio RA, Hong CH, Cao J, Kirn A, Schiller GJ, Lichtenstein AK, et al. The haematopoietic stem cell antigen, CD34 is not expressed on the malignant cells in multiple myeloma. Blood 1994;84:3283-7.
23. Gibson J, Pope B, Peterson A, Brown R, Jameson S, Luo XF, et al. GCSF stimulated PBSC harvests in myeloma contain immature malignant plasma cells (abstract). Blood 1994;84(Suppl l):108a.